Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Enterprise value to EBITDA ratio
Percentile
P79
Within normal range
vs 2Y Ago
-0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -0.70 | -286.9% |
| 2023 | 0.38 | -67.7% |
| 2022 | 1.17 | +1008.5% |
| 2021 | -0.13 | +97.4% |
| 2020 | -4.86 | +8.5% |
| 2019 | -5.32 | -237.6% |
| 2018 | -1.57 | +92.0% |
| 2017 | -19.62 | -662.3% |
| 2016 | -2.57 | +75.0% |
| 2015 | -10.27 | - |